Photo by lawlesscapture from unsplash
RE-LY2 Ensayo clínico 18.113 Dabigatrán 150 mg/12 h vs. warfarina 1,11 vs. 1 HR: 0,66 p < 0,001 Dabigatrán 110 mg/12 h vs. warfarina 1,53 vs. 1 HR: 0,91 p… Click to show full abstract
RE-LY2 Ensayo clínico 18.113 Dabigatrán 150 mg/12 h vs. warfarina 1,11 vs. 1 HR: 0,66 p < 0,001 Dabigatrán 110 mg/12 h vs. warfarina 1,53 vs. 1 HR: 0,91 p = 0,34 ROCKET-AF3 Ensayo clínico 14.264 Rivaroxabán vs. warfarina 2,1 vs. 2, HR: 0,88 p = 0,12 ARISTOTLE4 Ensayo clínico 18.201 Apixabán vs. warfarina 1,27 vs. 1 HR: 0,79 p = 0,01 Graham et al.5, 2015 Vida real 134.414 Dabigatrán (150 o 75 mg/12 h) vs. warfarina 1,13 vs. 1 HR: 0,8 ( p = 0,02d Yao et al.6, 2016b Voda real 125.243 Dabigatrán (150 o 75 mg/12 h) vs. warfarina 1,18 vs. 1 HR: 0,98 p = 0,88 Apixabán (5 o 2,5 mg/12 h) vs. warfarina 1,33 vs. 1 HR: 0,67 p = 0,04 Rivaroxabán (20 o 15 mg/24 h) vs. warfarina 1,26 vs. 1 HR: 0,93 p = 0,56
Journal Title: Medicina clinica
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!